Step four: ongoing support and dose adjustments The program does not end when medication arrives
This agonist is designed to mimic two human polypeptide hormones, namely glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), thus slowing down food digestion
During month two, the majority of patients begin seeing steady downward movement on the scale
Current Areas of Scientific Investigation While there are not current studies evaluating the combination of methionine, choline, carnitine, and dexpanthenol, there are studies evaluating individual ingredients
The Future of GLP-1 in Addiction Treatment Scientists and pharmaceutical companies are already working to determine which variations of GLP-1s may work for those struggling with addiction, and it might not be long before Ozempic for addiction becomes commonplace